The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections
Open accessAbstract
Despite significant research efforts aimed at understanding the neurobiological underpinnings of psychiatric disorders, the diagnosis and the evaluation of treatment of these disorders are still based solely on relatively subjective assessment of symptoms. Therefore, biological markers which could improve the current classification of psychiatry disorders, and in perspective stratify patients on a biological basis into more homogeneous clinically distinct subgroups, are highly needed. In order to identify novel candidate biological markers for major depression and schizophrenia, we have applied a focused proteomic approach using plasma samples from a large case-control collection. Patients were diagnosed according to DSM criteria using structured interviews and a number of additional clinical variables and demographic information were assessed. Plasma samples from 245 depressed patients, 229 schizophrenic patients and 254 controls were submitted to multi analyte profiling allowing the evaluation of up to 79 proteins, including a series of cytokines, chemokines and neurotrophins previously suggested to be involved in the pathophysiology of depression and schizophrenia. Univariate data analysis showed more significant p-values than would be expected by chance and highlighted several proteins belonging to pathways or mechanisms previously suspected to be involved in the pathophysiology of major depression or schizophrenia, such as insulin and MMP-9 for depression, and BDNF, EGF and a number of chemokines for schizophrenia. Multivariate analysis was carried out to improve the differentiation of cases from controls and identify the most informative panel of markers. The results illustrate the potential of plasma biomarker profiling for psychiatric disorders, when conducted in large collections. The study highlighted a set of analytes as candidate biomarker signatures for depression and schizophrenia, warranting further investigation in independent collections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
An introduction to ROC analysis
Fawcett, T. (2006) · Pattern Recognition Letters · doi:10.1016/j.patrec.2005.10.010 · Cited by 21,879
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 1×
“Multi-analyte and array profiling techniques enable the simultaneous detection of hundreds of proteins with high sensitivity and accuracy and can be successfully applied to identify biomarkers (or clusters of biomarkers) that correlate with disease [7].”
BackgroundCytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Wittchen, H.-U., Lachner, G., Wunderlich, U., & Pfister, H. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050095 · Cited by 668
Cited by
Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
Chen, W., Liu, F., Ling, Z., Tong, X., & Xiang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039743 · Cited by 1,034
A review of depression and suicide risk assessment using speech analysis
Cummins, N., Scherer, S., Krajewski, J., Schnieder, S., Epps, J., & Quatieri, T. F. (2015) · Speech Communication · doi:10.1016/j.specom.2015.03.004 · Cited by 1,003
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Treatment-resistant depression and peripheral C-reactive protein.
Chamberlain, S. R., Cavanagh, J., de Boer, P., Mondelli, V., Jones, D. N. C., Drevets, W. C., Cowen, P. J., Harrison, N. A., Pointon, L., Pariante, C. M., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.66 · Cited by 400
Self-citationHashimoto, K. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02113.x · Cited by 388
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Vafadari, B., Salamian, A., & Kaczmarek, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 382
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P., & Abbott, N. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 307
Blood-brain barrier regulation in psychiatric disorders
Kealy, J., Greene, C., & Campbell, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.033 · Cited by 307
Leighton, S. P., Nerurkar, L., Krishnadas, R., Johnman, C., Graham, G. J., & Cavanagh, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.205 · Cited by 291
Yoshida, T., Ishikawa, M., Niitsu, T., Nakazato, M., Watanabe, H., Shiraishi, T., Shiina, A., Hashimoto, T., Kanahara, N., Hasegawa, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042676 · Cited by 277
Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?
Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-10.2010 · Cited by 223
MMPs in learning and memory and neuropsychiatric disorders
Beroun, A., Mitra, S., Michaluk, P., Pijet, B., Stefaniuk, M., & Kaczmarek, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03180-8 · Cited by 207
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
A meta-analysis of chemokines in major depression
Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188
Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood
Lee, S.-H., Zabolotny, J. M., Huang, H., Lee, H., & Kim, Y.-B. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.011 · Cited by 176
“Indeed, in a recent plasma proteomics study aimed at identifying peripheral markers of MDD, the analyte with the greatest differential expression and statistical significance between healthy and MDD subjects was insulin [132].”
BackgroundImaging of Thalamocortical Dysrhythmia in Neuropsychiatry
Schulman, J. J., Cancro, R., Lowe, S., Lu, F., Walton, K. D., & Llinás, R. R. (2011) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2011.00069 · Cited by 167
Haapakoski, R., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.012 · Cited by 157
Cui, X., Niu, W., Kong, L., He, M., Jiang, K., Chen, S., Zhong, A., Li, W., Lu, J., & Zhang, L. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0130 · Cited by 150
Liu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119
“Interestingly, increased MMP9 in circulation is associated with mood disorders such as depression and bipolar disorder (Domenici et al., 2010; Rybakowski et al., 2013).”
BackgroundThe role of lipid biomarkers in major depression
Parekh, A., Smeeth, D., Milner, Y., & Thuret, S. (2017) · Healthcare · doi:10.3390/healthcare5010005 · Cited by 120
Diniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.76 · Cited by 116
VEGF and depression: A comprehensive assessment of clinical data
Clark-Raymond, A., & Halaris, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.04.008 · Cited by 108
Lopez, J. P., Kos, A., & Turecki, G. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000379 · Cited by 108
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients
Stelzhammer, V., Haenisch, F., Chan, M. K., Cooper, J. D., Steiner, J., Steeb, H., Martins-de-Souza, D., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000819 · Cited by 105
Yamamori, H., Hashimoto, R., Ishima, T., Kishi, F., Yasuda, Y., Ohi, K., Fujimoto, M., Umeda-Yano, S., Ito, A., Hashimoto, K., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.059 · Cited by 101
“he serum levels of MMP-9 have been reported to be increased n patients with schizophrenia [2].”
BackgroundPinto, J. V., Moulin, T. C., & Amaral, O. B. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.001 · Cited by 103
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Bested, A. C., Logan, A. C., & Selhub, E. M. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-4 · Cited by 84
Wiera, G., Wozniak, G., Bajor, M., Kaczmarek, L., & Mozrzymas, J. W. (2013) · Hippocampus · doi:10.1002/hipo.22112 · Cited by 57
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
Chemokine profile in women with moderate to severe anxiety and depression during pregnancy
Camacho-Arroyo, I., Flores-Ramos, M., Mancilla-Herrera, I., Cruz, F. M. C., Hernández-Ruiz, J., Diaz, G. P., Labonne, B. F., del Pilar Meza-Rodríguez, M., & Gelman, P. L. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04225-2 · Cited by 41
Al Awam, K., Haußleiter, I. S., Dudley, E., Donev, R., Brüne, M., Juckel, G., & Thome, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1224-0 · Cited by 42
Llorens-Martín, M., Jurado-Arjona, J., Bolós, M., Pallas-Bazarra, N., & Ávila, J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.019 · Cited by 43
Lepeta, K., Purzycka, K. J., Pachulska‐Wieczorek, K., Mitjans, M., Begemann, M., Vafadari, B., Bijata, K., Adamiak, R. W., Ehrenreich, H., Dziembowska, M., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707723 · Cited by 39
Serum folate levels in bipolar disorder: a systematic review and meta-analysis
Hsieh, Y.-C., Chou, L.-S., Lin, C.-H., Wu, H.-C., Li, D.-J., & Tseng, P.-T. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2269-2 · Cited by 33
Depression in type 1 diabetes was associated with high levels of circulating galectin-3
Melin, E. O., Dereke, J., Thunander, M., & Hillman, M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0108 · Cited by 31
Polacchini, A., Girardi, D., Falco, A., Zanotta, N., Comar, M., De Carlo, N. A., & Tongiorgi, E. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.02.002 · Cited by 30
“…chemokine levels, including CCL2/ MCP-1 and CCL11/Eotaxin, were found in cerebrospinal fluid (CSF) of suicide attempters respect to healthy controls (Janelidze et al., 2013), and increased CCL5/RANTES was found in schizophrenic patients but not in major-depressive subjects (Domenici et al., 2010).”
BackgroundMonocyte Chemoattractant Protein-1 Levels Are Associated with Major Depressive Disorder
Proma, M. A., Daria, S., Nahar, Z., Ashraful Islam, S. M., Bhuiyan, M. A., & Islam, M. R. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0132 · Cited by 29
Rahimi, S., Sayad, A., Moslemi, E., Ghafouri-Fard, S., & Taheri, M. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0043-z · Cited by 24
Lundberg, A. K., Jönsson, S., Stenmark, J., Kristenson, M., & Jonasson, L. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.07.219 · Cited by 24
Dickerson, F., Vaidya, D., Liu, Y., & Yolken, R. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2023.02.007 · Cited by 18
Wang, F., Guo, L., Zhang, T., Cui, Z., Wang, J., Zhang, C., Xue, F., Zhou, C., Li, B., Tan, Q., et al. (2022) · Medicina · doi:10.3390/medicina58111509 · Cited by 18
Senserrich, J., Castro, E., Florensa-Zanuy, E., Díaz, Á., Pazos, Á., Adell, A., Tzinia, A., & Pilar-Cuéllar, F. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00716-5 · Cited by 2
Metadata
- Authors
- Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., Holsboer, F., Bullmore, E. T., Middleton, L., Merlo-Pich, E., Alexander, R. C., & Muglia, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-11
- Volume
- 5
- Issue
- 2
- Pages
- e9166
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2007353040
- Cited by
- 347
- References
- 54
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.